Healthcare
ABCL
AbCellera Biologics Inc.
$11.35-8.47%
Add to Watchlist
Loading chart...
About AbCellera Biologics Inc.
AbCellera is a biotech company that discovers and develops antibody-based medicines, which are drugs made from proteins that help the immune system fight disease. The company is testing medicines for conditions like hot flashes and skin diseases. AbCellera partners with larger pharmaceutical companies including Eli Lilly, AbbVie, and Biogen to research and develop these drugs. The company is headquartered in Vancouver, Canada.
Full research is for ConvictionStocks members
Get Full AccessAnalyst Coverage
Full research is for ConvictionStocks members
Get Full AccessRecent News
Full research is for ConvictionStocks members
Get Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore